ATROPINE Side Effects

6718354-X | Cardiac Arrest, Hypotension, Rhabdomyolysis
on Apr 25, 2010 Female patient from INDIA , 25 years of age, was diagnosed with palpitations and was treated with Atropine (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), hypotension, rhabdomyolysis. Atropine dosage: .

6668281-1 | Dysuria
Patient was taking Atropine (View Usage). Patient had the following side effects: dysuria on Apr 05, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 185.0 lb, was diagnosed with preoperative care and. Atropine dosage: 1 Drop 2x Day Eye. Patient was hospitalized.

6608352-9 | Convulsion, Cyanosis, Dyspnoea, Electromechanical Dissociation, Hypotonia, Nausea
Adverse event was reported on Feb 22, 2010 by a Male patient taking Atropine (View Usage) (Dosage: ) was diagnosed with chest x-ray abnormal, computerised tomogram and. Location: UNITED STATES , 68 years of age, weighting 275.6 lb, After Atropine was administered, patient had the following side effects: convulsion, cyanosis, dyspnoea, electromechanical dissociation, hypotonia, nausea (What is nausea?). During the same period patient was treated with ISOVUE 128 (View Isovue-128 Review and Isovue-128 Label ), ISOVUE 128 (View Isovue-128 Review and Isovue-128 Label ), EPIPEN (View Epipen Review and Epipen Label ), EPINEPHRINE (View Epinephrine Review and Epinephrine Label ).

6595929-2 | Convulsion, Cyanosis, Dyspnoea, Electromechanical Dissociation, Hypotonia, Nausea
on Feb 12, 2010 Male patient from UNITED STATES , 68 years of age, weighting 275.6 lb, was diagnosed with chest x-ray abnormal, computerised tomogram and was treated with Atropine (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, cyanosis, dyspnoea, electromechanical dissociation, hypotonia, nausea (What is nausea?). Atropine dosage: . During the same period patient was treated with ISOVUE 128 (View Isovue-128 Review and Isovue-128 Label ), ISOVUE 128 (View Isovue-128 Review and Isovue-128 Label ), EPIPEN (View Epipen Review and Epipen Label ), EPINEPHRINE (View Epinephrine Review and Epinephrine Label ).


6587676-8 | Hallucination
on Feb 17, 2010 Male patient from UNITED STATES , child 6 years of age, weighting 52.00 lb, was diagnosed with amblyopia and was treated with Atropine (View Usage). Patient had the following side effects: hallucination. Atropine dosage: 1 Drop Daily Opthalmic.

6498188-4 | Cardiac Arrest, Pneumonia, Unresponsive To Stimuli
Patient was taking Atropine (View Usage). After Atropine was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), pneumonia (What is pneumonia?), unresponsive to stimuli on Nov 30, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 38 years of age, weighting 92.59 lb, was diagnosed with cardiac arrest (What is cardiac arrest?) and. Atropine dosage: . During the same period patient was treated with ADRENALINE (View Adrenaline Review and Adrenaline Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ).

6485904-0 | Anxiety, Chest Discomfort, Sinus Tachycardia, Stress Cardiomyopathy, Syncope
Adverse event was reported on Nov 26, 2009 by a Female patient taking Atropine (View Usage) (Dosage: . 8 Mg, Intravenous) was diagnosed with hypotension, sinus bradycardia and. Location: UNITED STATES , 31 years of age, Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), chest discomfort, sinus tachycardia, stress cardiomyopathy, syncope. During the same period patient was treated with (EPHEDRINE) (50 Mg, Intravenous) (View (ephedrine) Review and (ephedrine) Label ), (PHENYLEPHNINE) (Intravenous Drip) (View (phenylephnine) Review and (phenylephnine) Label ), BUPIVACAINE (View Bupivacaine Review and Bupivacaine Label ), FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ), MORPHINE (View Morphine Review and Morphine Label ), (NITROUS OXIDE) (View (nitrous Oxide) Review and (nitrous Oxide) Label ). Patient was hospitalized.

6315539-1 | Eosinophilia, Pyrexia, Rash Maculo-papular
on Jul 30, 2009 Male patient from FRANCE , 40 years of age, was diagnosed with ulcerative keratitis, surgery (What is surgery?), fungal infection (What is fungal infection?) and was treated with Atropine (View Usage). Patient had the following side effects: eosinophilia, pyrexia, rash maculo-papular. Atropine dosage: . During the same period patient was treated with INDOCOLLYRE 0.1% COLLYRE (View Indocollyre 0.1% Collyre Review and Indocollyre 0.1% Collyre Label ), PRIMAXIN (View Primaxin Review and Primaxin Label ), TAVANIC (View Tavanic Review and Tavanic Label ), CILOXAN (View Ciloxan Review and Ciloxan Label ), REFRESH (View Refresh Review and Refresh Label ), MYDRIATICUM (View Mydriaticum Review and Mydriaticum Label ), FUNGIZONE /USA/ (View Fungizone /usa/ Review and Fungizone /usa/ Label ), PEVARYL (View Pevaryl Review and Pevaryl Label ). Patient was hospitalized.

6230278-3 | Anaphylactic Reaction, Bradycardia, Cardio-respiratory Arrest
on Jun 03, 2009 Female patient from UNITED KINGDOM , 56 years of age, was diagnosed with prophylaxis and was treated with Atropine (View Usage). After Atropine was administered, patient had the following side effects: anaphylactic reaction, bradycardia, cardio-respiratory arrest. Atropine dosage: . During the same period patient was treated with TAZOCIN (View Tazocin Review and Tazocin Label ).

6123149-4 | Electrocardiogram St Segment Depression, Ventricular Extrasystoles
Patient was taking Atropine (View Usage). Patient experienced the following unwanted or unexpected effects: electrocardiogram st segment depression, ventricular extrasystoles on Mar 09, 2009 from JAPAN Additional patient health information: Female patient , 30 years of age, weighting 127.9 lb, was diagnosed with blood pressure decreased, heart rate decreased and. Atropine dosage: . During the same period patient was treated with EPHEDRINE (View Ephedrine Review and Ephedrine Label ), THIOPENTAL SODIUM (View Thiopental Sodium Review and Thiopental Sodium Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ), VASOPRESSIN INJECTION (View Vasopressin Injection Review and Vasopressin Injection Label ).

6115892-8 | Angle Closure Glaucoma
Adverse event was reported on Feb 25, 2009 by a Male patient taking Atropine (View Usage) (Dosage: (ophthalmic)) . Location: UNITED STATES , 55 years of age, Patient had the following side effects: angle closure glaucoma.

6098167-5 | Electrocardiogram St Segment Depression, Ventricular Extrasystoles
on Feb 16, 2009 Female patient from JAPAN , 30 years of age, was diagnosed with blood pressure decreased, heart rate decreased and was treated with Atropine (View Usage). After Atropine was administered, patient had the following side effects: electrocardiogram st segment depression, ventricular extrasystoles. Atropine dosage: . During the same period patient was treated with EPHEDRINE (View Ephedrine Review and Ephedrine Label ), THIOPENTAL SODIUM (View Thiopental Sodium Review and Thiopental Sodium Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ), VASOPRESSIN INJECTION (View Vasopressin Injection Review and Vasopressin Injection Label ).

6073063-8 | Asthenia, Constipation, Dry Mouth, Dysuria, Flushing, Headache, Hypophagia, Urinary Hesitation
on Feb 09, 2009 Male patient from UNITED STATES , 70 years of age, weighting 275.0 lb, was diagnosed with cardiac stress test and was treated with Atropine (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, constipation (What is constipation?), dry mouth, dysuria, flushing, headache (What is headache?), hypophagia, urinary hesitation. Atropine dosage: .

5952378-5 | Blood Pressure Increased, Chest Pain, Headache, Heart Rate Increased, Nausea, Sinus Bradycardia
Patient was taking Atropine (View Usage). Patient had the following side effects: blood pressure increased, chest pain (What is chest pain?), headache (What is headache?), heart rate increased, nausea (What is nausea?), sinus bradycardia on Nov 02, 2008 from QATAR Additional patient health information: Female patient , 30 years of age, . Atropine dosage: . During the same period patient was treated with METHERGINE (View Methergine Review and Methergine Label ), BUPIVACAINE (View Bupivacaine Review and Bupivacaine Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), SALINE MIXTURE (View Saline Mixture Review and Saline Mixture Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ).

5911229-5 | Anterograde Amnesia, Disorientation
Adverse event was reported on Sep 24, 2008 by a Female patient taking Atropine (View Usage) (Dosage: ) was diagnosed with diagnostic procedure and. Location: SPAIN , 68 years of age, After Atropine was administered, patient had the following side effects: anterograde amnesia, disorientation. During the same period patient was treated with DOBUTAMINE HCL (View Dobutamine Hcl Review and Dobutamine Hcl Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ). Patient was hospitalized.

5896095-9 | Angle Closure Glaucoma
on Sep 11, 2008 Female patient from UNITED KINGDOM , 69 years of age, was diagnosed with cycloplegia, eye inflammation, glaucoma (What is glaucoma?) and was treated with Atropine (View Usage). Patient experienced the following unwanted or unexpected effects: angle closure glaucoma. Atropine dosage: . During the same period patient was treated with BETAXOLOL (View Betaxolol Review and Betaxolol Label ), DORZOLAMIDE (View Dorzolamide Review and Dorzolamide Label ).

5833814-1 | Eczema, Flushing
on Aug 01, 2008 Male patient from UNITED STATES , 76 years of age, was diagnosed with eye disorder and was treated with Atropine (View Usage). Patient had the following side effects: eczema (What is eczema?), flushing. Atropine dosage: 1 Drops Every Day Eye.

5691809-5 | Blood Cholesterol Increased, Blood Triglycerides Increased, Disorientation, Dry Mouth, Dry Throat, Eye Infection, Headache, Hyperacusis
Patient was taking Atropine (View Usage). After Atropine was administered, patient had the following side effects: blood cholesterol increased, blood triglycerides increased, disorientation, dry mouth, dry throat, eye infection (What is eye infection?), headache (What is headache?), hyperacusis on Apr 01, 2008 from UNITED STATES Additional patient health information: Female patient , 57 years of age, weighting 167.0 lb, was diagnosed with ophthalmological examination, corrective lens user and. Atropine dosage: 5 Drops Once Ophthalmic. During the same period patient was treated with TROPICAMIDE (2 Drops Of One , And 2 Another Once Ophthalmic) (View Tropicamide Review and Tropicamide Label ), SCOPOLAMINE (View Scopolamine Review and Scopolamine Label ), CYCLOGYL (View Cyclogyl Review and Cyclogyl Label ).

5671869-8 | Disorientation, Dizziness, Dysphagia, Dysstasia, Eye Movement Disorder, Hallucination, Visual Disturbance
Adverse event was reported on Mar 17, 2008 by a Female patient taking Atropine (View Usage) (Dosage: ) . Location: UNITED STATES , 86 years of age, weighting 156.0 lb, Patient experienced the following unwanted or unexpected effects: disorientation, dizziness (What is dizziness?), dysphagia, dysstasia, eye movement disorder, hallucination, visual disturbance. Patient was hospitalized.

5564281-3 | Body Temperature Increased, Food Intolerance, Heart Rate Increased, No Therapeutic Response, Tremor
on Dec 14, 2007 Female patient from UNITED STATES , weighting 4.96 lb, was treated with Atropine (View Usage). Patient had the following side effects: body temperature increased, food intolerance, heart rate increased, no therapeutic response, tremor. Atropine dosage: 1 Drop In Each Eye Every Evening Ophthalmic. During the same period patient was treated with ALBUTEROL NEBULIZED (View Albuterol -nebulized- Review and Albuterol -nebulized- Label ), CYCLOPENTOLATE/PHENYLEPHRINE (View Cyclopentolate/phenylephrine Review and Cyclopentolate/phenylephrine Label ), PROPARACAINE HCL (View Proparacaine Hcl Review and Proparacaine Hcl Label ).

5368627-0 | Bedridden, Cardiopulmonary Failure, Pneumonia
on Jun 21, 2007 Male patient from UNITED STATES , 86 years of age, weighting 140.0 lb, was treated with Atropine (View Usage). After Atropine was administered, patient had the following side effects: bedridden, cardiopulmonary failure, pneumonia (What is pneumonia?). Atropine dosage: Adult 2x. Patient was hospitalized.

5135924-3 | Abnormal Sensation In Eye, Headache, Impaired Work Ability, Loss Of Employment, Mydriasis, Photophobia, Visual Field Defect
Patient was taking Atropine (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal sensation in eye, headache (What is headache?), impaired work ability, loss of employment, mydriasis, photophobia, visual field defect on Oct 04, 2006 from FRANCE Additional patient health information: Male patient , 41 years of age, was diagnosed with diagnostic procedure, uveitis and. Atropine dosage: Opht. During the same period patient was treated with TOBRAMYCIN + DEXAMETHASONE (View Tobramycin + Dexamethasone Review and Tobramycin + Dexamethasone Label ), DEXAMETHASONE/OXYTETRACYCLINE (View Dexamethasone/oxytetracycline Review and Dexamethasone/oxytetracycline Label ).

5080361-3 | Respiratory Arrest
Adverse event was reported on Aug 14, 2006 by a Male patient taking Atropine (View Usage) (Dosage: 2 Drops Once Po One Dose) was diagnosed with respiratory disorder and. Location: UNITED STATES , 78 years of age, weighting 175.0 lb, Patient had the following side effects: respiratory arrest.

5066081-X | Abnormal Sensation In Eye, Headache, Loss Of Employment, Mydriasis, Photophobia, Visual Field Defect
on Jul 06, 2006 Male patient from FRANCE , 41 years of age, was diagnosed with refraction disorder, uveitis and was treated with Atropine (View Usage). After Atropine was administered, patient had the following side effects: abnormal sensation in eye, headache (What is headache?), loss of employment, mydriasis, photophobia, visual field defect. Atropine dosage: Opht. During the same period patient was treated with TOBRAMYCIN + DEXAMETHASONE (View Tobramycin + Dexamethasone Review and Tobramycin + Dexamethasone Label ), DEXAMETHASONE/OXYTETRACYCLINE (View Dexamethasone/oxytetracycline Review and Dexamethasone/oxytetracycline Label ).

5022495-5 | Abnormal Sensation In Eye, Headache, Impaired Work Ability, Mydriasis, Photophobia, Visual Field Defect
on May 22, 2006 Male patient from FRANCE , 41 years of age, was diagnosed with refraction disorder, uveitis and was treated with Atropine (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal sensation in eye, headache (What is headache?), impaired work ability, mydriasis, photophobia, visual field defect. Atropine dosage: Opht. During the same period patient was treated with TOBRAMYCIN + DEXAMETHASONE (View Tobramycin + Dexamethasone Review and Tobramycin + Dexamethasone Label ), DEXAMETHASONE/OXYTETRACYCLINE (View Dexamethasone/oxytetracycline Review and Dexamethasone/oxytetracycline Label ).

5005560-8 | Abnormal Sensation In Eye, Headache, Loss Of Employment, Mydriasis, Photophobia, Visual Field Defect
Patient was taking Atropine (View Usage). Patient had the following side effects: abnormal sensation in eye, headache (What is headache?), loss of employment, mydriasis, photophobia, visual field defect on Apr 25, 2006 from FRANCE Additional patient health information: Male patient , 41 years of age, was diagnosed with refraction disorder, therapeutic procedure, uveitis and. Atropine dosage: Opht. During the same period patient was treated with TOBRAMYCIN + DEXAMETHASONE (View Tobramycin + Dexamethasone Review and Tobramycin + Dexamethasone Label ), DEXAMETHASONE/OXYTETRACYCLINE (View Dexamethasone/oxytetracycline Review and Dexamethasone/oxytetracycline Label ).

4930966-2 | Ventricular Tachycardia
Adverse event was reported on Jan 25, 2006 by a Female patient taking Atropine (View Usage) (Dosage: 0.2 Mg; Iv) was diagnosed with myringotomy and. Location: TAIWAN, PROVINCE OF CHINA , child 9 years of age, After Atropine was administered, patient had the following side effects: ventricular tachycardia. During the same period patient was treated with THIOPENTAL SODIUM (View Thiopental Sodium Review and Thiopental Sodium Label ), ATRACURIUM BESYLATE (View Atracurium Besylate Review and Atracurium Besylate Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ).

4731295-2 | Confusional State, Erectile Dysfunction, Priapism, Sedation
on Jul 29, 2005 Male patient from UNITED STATES , 45 years of age, weighting 257.0 lb, was diagnosed with nicotine dependence and was treated with Atropine (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state, erectile dysfunction (What is erectile dysfunction?), priapism, sedation. Atropine dosage: 0.2 Mg, 0.4 Mg Subcutaneous. During the same period patient was treated with SCOPOLAMINE (0.2 Mg 0.4 Mg Subcutaneous) (View Scopolamine Review and Scopolamine Label ), INTRATHECAL MORPHINE (View Intrathecal Morphine Review and Intrathecal Morphine Label ). Patient was hospitalized and became disabled.

4673289-1 | Atrial Fibrillation, Chest Pain, Dyspnoea, Electrocardiogram St Segment Depression, Myocardial Ischaemia
on May 24, 2005 Male patient from , 75 years of age, weighting 256.2 lb, was treated with Atropine (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), chest pain (What is chest pain?), dyspnoea, electrocardiogram st segment depression, myocardial ischaemia. Atropine dosage: 0.2 Mg Sq. During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), RINOTECAN 110 MG IN DEXTROSE 5% (View Rinotecan 110 Mg In Dextrose 5% Review and Rinotecan 110 Mg In Dextrose 5% Label ), MAGNESIUM SULFATE (50%) 1 GM IN 500 ML NS (View Magnesium Sulfate (50%) 1 Gm In 500 Ml Ns Review and Magnesium Sulfate (50%) 1 Gm In 500 Ml Ns Label ), ONDANSETRON 16 MG IN DEXTROSE 5% (View Ondansetron 16 Mg In Dextrose 5% Review and Ondansetron 16 Mg In Dextrose 5% Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

4620847-6 | Visual Acuity Reduced
Patient was taking Atropine (View Usage). After Atropine was administered, patient had the following side effects: visual acuity reduced on Mar 11, 2005 from Additional patient health information: Male patient , child 3 years of age, was diagnosed with amblyopia and. Atropine dosage: .